Screening CRC patients for Lynch syndrome ‘cost-effective’
Extensive Australian analysis suggests screening by testing for DNA mismatch repair deficiency
Screening all cases of incident colorectal cancer in Australia for Lynch syndrome would be cost-effective, and save about 80 deaths a year, according to the most comprehensive analysis to date.
The results extend the findings of two earlier studies, including one by the Department of Health’s Medical Service Advisory Committee (MSAC), that show such screening can be cost-effective, the authors of the new study write in the MJA.
